About this trial
This study aims to obtain data on the potential influence of Vine to Bar product(s) containing Chardonnay marc on cardiometabolic health. These initial studies will inform the design and timing of data collection for future dietary intervention trials that will examine the influence of Chardonnay marc intake on outcomes/biomarkers of both cardiometabolic health and the gut microbiome. This includes collecting data on the potential differences in response to the products based on the unique food matrix for each of the products that will be tested. Moreover, as there is a paucity of data on the influence of cocoa flavanol intake on vascular function beyond 4 hours post intake, the response of the selected outcomes will be assessed after 6 hours of flavanol intake. This is a time point that captures the increased circulating presence of microbial derived flavanol metabolites.
Eligibility criteria
Qualifiers
Screening or Visit 1 Reactive Hyperemia Index (RHI; EndoPAT 2000) < 2.0
Subject is willing and able to comply with the study protocols.
Subject is willing to participate in all study procedures
BMI 25.0 - 35 kg/m2
Disqualifiers
BMI ≥ 35 kg/m2
Indivduals that weight less than a 110 lbs
Donation of blood within the previous 30 days
Visit 1 Reactive Hyperemia Index (RHI; EndoPAT 2000) ≥ 2.0
Trial design
Treatments tested in this trial
- Low Flavanol Cocoa Powder
- High Flavanol Cocoa Powder
- Vine to Bar Chocolate - 2 servings
- Vine to Bar Chocolate - 1 serving
- Vine to Bar Chocolate covered almonds